Mucopolysaccharidosis Type I
What's New
Last Posted: Apr 27, 2023
- Implementation of Newborn Screening for Conditions in the United States First Recommended during 2010-2018.
Sikha Singh et al. Int J Neonatal Screen 9(2) - Implementation of Newborn Screening for Conditions in the United States First Recommended during 2010–2018
S Singh et al, IJNS, April 2023 - Addition of MPS-II to the Recommended Uniform Screening Panel in the United States
DS Millington et al, IJNS, October 11, 2022 - A rapid and non-invasive proteomic analysis using DBS and buccal swab for multiplexed second-tier screening of Pompe disease and Mucopolysaccharidosis type I.
Zhang Tong et al. Molecular genetics and metabolism 2022 - Hematopoietic Stem- and Progenitor-Cell Gene Therapy for Hurler Syndrome
B Gentner et al, NEJM, November 18, 2021 - Mucopolysaccharidosis Type I Disease Prevalence Among Patients With Idiopathic Short Stature in Saudi Arabia: Protocol for a Multicenter Cross-sectional Study.
Alsafadi Danyah et al. JMIR research protocols 2021 10(8) e28619 - Incorporation of Second-Tier Biomarker Testing Improves the Specificity of Newborn Screening for Mucopolysaccharidosis Type I.
Peck Dawn S et al. International journal of neonatal screening 2020 Feb 6(1) - Current Practices for U.S. Newborn Screening of Pompe Disease and MPSI.
Ames Elizabeth G et al. International journal of neonatal screening 2020 Sep 6(3) - Report of Five Years of Experience in Neonatal Screening for Mucopolysaccharidosis Type I and Review of the Literature.
Gragnaniello Vincenza et al. International journal of neonatal screening 2020 Nov 6(4) - Implementing Statewide Newborn Screening for New Disorders: U.S. Program Experiences.
Kellar-Guenther Yvonne et al. International journal of neonatal screening 2020 Jun 6(2) 35 - Mucopolysaccharidosis type I newborn screening: Importance of second tier testing for ethnically diverse populations.
Bosfield Kerri et al. American journal of medical genetics. Part A 2020 Oct - A Comparative Effectiveness Study of Newborn Screening Methods for Four Lysosomal Storage Disorders.
Sanders Karen A et al. International journal of neonatal screening 2020 Jun 6(2) - Newborn screening of mucopolysaccharidoses: past, present, and future.
Arunkumar Nivethitha et al. Journal of human genetics 2020 Apr - Development of a newborn screening tool for mucopolysaccharidosis type I based on bivariate normal limits: Using glycosaminoglycan and alpha-L-iduronidase determinations on dried blood spots to predict symptoms.
Langan Thomas J et al. JIMD reports 2020 Mar 52(1) 35-42 - The North Carolina Experience with Mucopolysaccharidosis Type I Newborn Screening.
Taylor Jennifer L et al. The Journal of pediatrics 2019 May - Lessons Learned from Newborn Screening in Pilot Studies.
Taylor Jennifer L et al. North Carolina medical journal 80(1) 54-58 - Leveraging Evidence-Based Public Policy and Advocacy to Advance Newborn Screening in California.
Bronstein Max G et al. Pediatrics 2019 Jan - Newborn screening in mucopolysaccharidoses.
Donati Maria Alice et al. Italian journal of pediatrics 2018 Nov 44(Suppl 2) 126 - International working group identifies need for newborn screening for mucopolysaccharidosis type I but states that existing hurdles must be overcome.
Parini Rossella et al. Acta paediatrica (Oslo, Norway : 1992) 2018 Sep - CLINGEN Actionability Report for Mucopolysaccharidosis type I-IDUA
ClinGen Actionability Working Group - Treatment of thoracolumbar kyphosis in patients with mucopolysaccharidosis type I: results of an international consensus procedure.
Kuiper Gé-Ann et al. Orphanet journal of rare diseases 2019 14(1) 17 - IDUA mutational profile and genotype-phenotype relationships in UK patients with Mucopolysaccharidosis Type I.
Ghosh Arunabha et al. Human mutation 2017 Nov 38(11) 1555-1568 - Open issues in Mucopolysaccharidosis type I-Hurler.
Parini Rossella et al. Orphanet journal of rare diseases 2017 Jun 12(1) 112 - Long-term outcomes of systemic therapies for Hurler syndrome: an international multicenter comparison.
Eisengart Julie B et al. Genetics in medicine : official journal of the American College of Medical Genetics 2018 Mar - Newborn screening for lysosomal storage disorders by tandem mass spectrometry in North East Italy.
Burlina Alberto B et al. Journal of inherited metabolic disease 2017 Nov - Precision newborn screening for lysosomal disorders.
Minter Baerg Melissa M et al. Genetics in medicine : official journal of the American College of Medical Genetics 2017 Nov - Newborn screening for six lysosomal storage disorders in a cohort of Mexican patients: Three-year findings from a screening program in a closed Mexican health system.
Navarrete-Martínez Juana Inés et al. Molecular genetics and metabolism 2017 Mar - Mucopolysaccharidosis Type I Newborn Screening: Best Practices for Diagnosis and Management.
Clarke Lorne A et al. The Journal of pediatrics 2016 Dec - Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (Hunter syndrome).
da Silva Edina Mk et al. The Cochrane database of systematic reviews 2016 Feb CD008185 - Mucopolysaccharidosis type I
From NCATS Genetic and Rare Diseases Information Center - Mucopolysaccharidosis type II
From NCATS Genetic and Rare Diseases Information Center - Mucopolysaccharidosis type III
From NCATS Genetic and Rare Diseases Information Center - Mucopolysaccharidosis type IIIA
From NCATS Genetic and Rare Diseases Information Center - Mucopolysaccharidosis type IIIB
From NCATS Genetic and Rare Diseases Information Center - Mucopolysaccharidosis type IIIC
From NCATS Genetic and Rare Diseases Information Center - Mucopolysaccharidosis type IIID
From NCATS Genetic and Rare Diseases Information Center - Mucopolysaccharidosis type IV
From NCATS Genetic and Rare Diseases Information Center - Mucopolysaccharidosis type IVA
From NCATS Genetic and Rare Diseases Information Center - Mucopolysaccharidosis type VI
From NCATS Genetic and Rare Diseases Information Center - Mucopolysaccharidosis type VII
From NCATS Genetic and Rare Diseases Information Center
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: